Same Drug Class

Imatinib vs Upadacitinib

Imatinib vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Imatinib and Upadacitinib.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Upadacitinib — C17H19F3N6O.

Molecular Weight: Imatinib — 493.6030 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Imatinib — Small molecule; Upadacitinib — Small molecule.